MedTrace Logo

Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients

NCT04953013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 664

Last updated 2021-07-07

No results posted yet for this study

Summary

This study aimed to investigate whether hemodynamic status before SBT contributed to the effect of sodium bicarbonate infusion on the risk of neonatal organ dysfunction and mortality in critically ill patients with early metabolic acidosis in ICU.

Conditions

  • Metabolic Acidosis; Critically Ill Patients; Organ Dysfunction

Interventions

DRUG

sodium bicarbonate

Drug exposure

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-02-01
Completion
2020-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953013 on ClinicalTrials.gov